Julia Świechowska et al. 2026. MID-REGIONAL PRO-ADRENOMEDULLIN (MR-proADM) AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN EARLY SEPSIS: A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science. 2, 2(50) (Jun. 2026). DOI:https://doi.org/10.31435/ijitss.2(50).2026.5741.